Dynepo Long-Term Safety Study

NCT00514813 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

152

Enrollment

INDUSTRY

Sponsor class

Stopped The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA

Conditions

Anemia
Kidney Failure, Chronic

Interventions

DRUG: Dynepo

Sponsor

Shire